We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
Products / PRODUCT LIST
API product portfolio

API PRODUCT PORTFOLIO

Inke's products are high-added-value active pharmaceutical ingredients (APIs),
mainly for use in respiratory inhalation and CNS therapies
API Indication Micronised CEP EU DMF US DMF JP DMF KR DMF CN DMF
Abediterol Asthma and COPD
Aclidinium bromide COPD
Apixaban p Venous thromboembolism
Aprepitant Emesis
Arformoterol tartrate (A) COPD
Arformoterol tartrate (D) p COPD
Asenapine p Schizophrenia and acute mania
Batefenterol COPD
Brexpiprazole Schizophrenia and major depressive disorders
Brivaracetam Antiepileptic
Carvedilol p Hypertension, angina, heart failure
Cinacalcet Hyperparathyroidism / Hypercalcaemia
Clevidipine p Hypertension
Clomethiazole Insomnia
Crisaborole p Atopic dermatitis and psoriasis
Desloratadine Allergy
Dronedarone p Atrial fibrillation & general arrhythmia
Eletriptan HBr p Migraine
Enalapril maleate p Hypertension
Fluconazol p Antifungal
INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain marketing authorisation. In particular, these products are developed for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC, i.e activities carried out to obtain marketing authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.


© Neuraxpharm / INKE. All rights reserved.